The future of clinical development is digital. From wearable sensors to AI-powered analysis, sponsors who embrace digital strategies will gain faster decisions, better data, and stronger regulatory confidence. Get a ste...
In the News
ICON experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
Oncology & ASCO 2019: Moving from Autologous to Allogeneic ACT Paradigms
We have come so far in a relatively short time with Adoptive Cellular Transfer (ACT). ACT approaches have the possibilities of therapies with reduced safety concerns, a higher therapeutic index, as well as breadth of targets including solid tumours. Learn more in our recent Pharmaphorum article.
